X chromosome inactivation: Recent advances and a look forward

Current Opinion in Genetics and Development

Volumn 28, Issue , 2014, Pages 78-82

  Briggs, Sharon F ^a   Reijo Pera, Renee A ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MONTANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GROWTH; CANCER RISK; CARCINOGENESIS; CELL DIFFERENTIATION; CHROMATIN STRUCTURE; CHROMOSOME DUPLICATION; CHROMOSOME LOSS; GENE; GENE MUTATION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; HUMAN; NONHUMAN; NUCLEAR REPROGRAMMING; ONCOGENE; PLURIPOTENT STEM CELL; REVIEW; X CHROMOSOME INACTIVATION; XIST GENE; ANIMAL; CYTOLOGY; FEMALE; METABOLISM; MOUSE;

ANIMALS; CELLULAR REPROGRAMMING; FEMALE; HUMANS; MICE; PLURIPOTENT STEM CELLS; X CHROMOSOME INACTIVATION;

EID: 84908572183     PISSN: 0959437X     EISSN: 18790380     Source Type: Journal    
DOI: 10.1016/j.gde.2014.09.010     Document Type: Review

References (39)

1. Lyon M.F. Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature 1961, 190:372-373.
2. Lessing D., Anguera M.C., Lee J.T. X chromosome inactivation and epigenetic responses to cellular reprogramming. Annu Rev Genomics Hum Genet 2013, 14:85-110.
3. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
4. Sun S., Del Rosario B.C., Szanto A., Ogawa Y., Jeon Y., Lee J.T. Jpx RNA activates Xist by evicting CTCF. Cell 2013, 153:1537-1551.
5. Lee J.T., Davidow L.S., Warshawsky D. Tsix, a gene antisense to Xist at the X-inactivation centre. Nat Genet 1999, 21:400-404.
6. Jeon Y., Lee J.T. YY1 tethers Xist RNA to the inactive X nucleation center. Cell 2011, 146:119-133.
7. Zhao J., Sun B.K., Erwin J.A., Song J.J., Lee J.T. Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 2008, 322:750-756.
8. Chao W., Huynh K.D., Spencer R.J., Davidow L.S., Lee J.T. CTCF, a candidate trans-acting factor for X-inactivation choice. Science 2002, 295:345-347.
9. Engreitz J.M., Pandya-Jones A., McDonel P., Shishkin A., Sirokman K., Surka C., Kadri S., Xing J., Goren A., Lander E.S., et al. The Xist lncRNA exploits three-dimensional genome architecture to spread across the X chromosome. Science 2013, 341:1237973.
10. Vallot C., Huret C., Lesecque Y., Resch A., Oudrhiri N., Bennaceur-Griscelli A., Duret L., Rougeulle C. XACT, a long noncoding transcript coating the active X chromosome in human pluripotent cells. Nat Genet 2013, 45:239-241.
11. Migeon B.R., Chowdhury A.K., Dunston J.A., McIntosh I. Identification of TSIX, encoding an RNA antisense to human XIST, reveals differences from its murine counterpart: implications for X inactivation. Am J Hum Genet 2001, 69:951-960.
12. Migeon B.R., Lee C.H., Chowdhury A.K., Carpenter H. Species differences in TSIX/Tsix reveal the roles of these genes in X-chromosome inactivation. Am J Hum Genet 2002, 71:286-293.
13. da Rocha S.T., Boeva V., Escamilla-Del-Arenal M., Ancelin K., Granier C., Matias N.R., Sanulli S., Chow J., Schulz E., Picard C., et al. Jarid2 is implicated in the initial xist-induced targeting of PRC2 to the inactive X chromosome. Mol Cell 2014, 53:301-316.
14. Minkovsky A., Barakat T.S., Sellami N., Chin M.H., Gunhanlar N., Gribnau J., Plath K. The pluripotency factor-bound intron 1 of Xist is dispensable for X chromosome inactivation and reactivation in vitro and in vivo. Cell Rep 2013, 3:905-918.
15. Moore K.L., Barr M.L. The sex chromatin in benign tumours and related conditions in man. Br J Cancer 1955, 9:246-252.
16. Pageau G.J., Hall L.L., Ganesan S., Livingston D.M., Lawrence J.B. The disappearing Barr body in breast and ovarian cancers. Nat Rev Cancer 2007, 7:628-633.
17. Agrelo R., Wutz A. X inactivation and disease. Semin Cell Dev Biol 2010, 21:194-200.
18. Huang K.C., Rao P.H., Lau C.C., Heard E., Ng S.K., Brown C., Mok S.C., Berkowitz R.S., Ng S.W. Relationship of XIST expression and responses of ovarian cancer to chemotherapy. Mol Cancer Ther 2002, 1:769-776.
19. Richardson A.L., Wang Z.C., De Nicolo A., Lu X., Brown M., Miron A., Liao X., Iglehart J.D., Livingston D.M., Ganesan S. X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 2006, 9:121-132.
20. Jager N., Schlesner M., Jones D.T., Raffel S., Mallm J.P., Junge K.M., Weichenhan D., Bauer T., Ishaque N., Kool M., et al. Hypermutation of the inactive X chromosome is a frequent event in cancer. Cell 2013, 155:567-581.
21. Yildirim E., Kirby J.E., Brown D.E., Mercier F.E., Sadreyev R.I., Scadden D.T., Lee J.T. Xist RNA is a potent suppressor of hematologic cancer in mice. Cell 2013, 152:727-742.
22. Anguera M.C., Sadreyev R., Zhang Z., Szanto A., Payer B., Sheridan S.D., Kwok S., Haggarty S.J., Sur M., Alvarez J., et al. Molecular signatures of human induced pluripotent stem cells highlight sex differences and cancer genes. Cell Stem Cell 2012, 11:75-90.
23. Ohhata T., Wutz A. Reactivation of the inactive X chromosome in development and reprogramming. Cell Mol Life Sci 2013, 70:2443-2461.
24. Lyon M.F. Genetic activity of sex chromosomes in somatic cells of mammals. Philos Trans R Soc Lond B Biol Sci 1970, 259:41-52.
25. Maherali N., Sridharan R., Xie W., Utikal J., Eminli S., Arnold K., Stadtfeld M., Yachechko R., Tchieu J., Jaenisch R., et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 2007, 1:55-70.
26. Nichols J., Smith A. Naive and primed pluripotent states. Cell Stem Cell 2009, 4:487-492.
27. Tesar P.J., Chenoweth J.G., Brook F.A., Davies T.J., Evans E.P., Mack D.L., Gardner R.L., McKay R.D. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature 2007, 448:196-199.
28. Guo G., Yang J., Nichols J., Hall J.S., Eyres I., Mansfield W., Smith A. Klf4 reverts developmentally programmed restriction of ground state pluripotency. Development 2009, 136:1063-1069.
29. Mekhoubad S., Bock C., de Boer A.S., Kiskinis E., Meissner A., Eggan K. Erosion of dosage compensation impacts human iPSC disease modeling. Cell Stem Cell 2012, 10:595-609.
30. Gafni O., Weinberger L., Mansour A.A., Manor Y.S., Chomsky E., Ben-Yosef D., Kalma Y., Viukov S., Maza I., Zviran A., et al. Derivation of novel human ground state naive pluripotent stem cells. Nature 2013, 504:282-286.
31. Lagarkova M.A., Shutova M.V., Bogomazova A.N., Vassina E.M., Glazov E.A., Zhang P., Rizvanov A.A., Chestkov I.V., Kiselev S.L. Induction of pluripotency in human endothelial cells resets epigenetic profile on genome scale. Cell Cycle 2010, 9:937-946.
32. Marchetto M.C., Carromeu C., Acab A., Yu D., Yeo G.W., Mu Y., Chen G., Gage F.H., Muotri A.R. A model for neural development and treatment of Rett syndrome using human induced pluripotent stem cells. Cell 2010, 143:527-539.
33. Bogomazova A.N., Lagarkova M.A., Panova A.V., Nekrasov E.D., Kiselev S.L. Reactivation of X chromosome upon reprogramming leads to changes in the replication pattern and 5hmC accumulation. Chromosoma 2014, 123:117-128.
34. Tchieu J., Kuoy E., Chin M.H., Trinh H., Patterson M., Sherman S.P., Aimiuwu O., Lindgren A., Hakimian S., Zack J.A., et al. Female human iPSCs retain an inactive X chromosome. Cell Stem Cell 2010, 7:329-342.
35. Bruck T., Benvenisty N. Meta-analysis of the heterogeneity of X chromosome inactivation in human pluripotent stem cells. Stem Cell Res 2011, 6:187-193.
36. Tomoda K., Takahashi K., Leung K., Okada A., Narita M., Yamada N.A., Eilertson K.E., Tsang P., Baba S., White M.P., et al. Derivation conditions impact X-inactivation status in female human induced pluripotent stem cells. Cell Stem Cell 2012, 11:91-99.
37. Lengner C.J., Gimelbrant A.A., Erwin J.A., Cheng A.W., Guenther M.G., Welstead G.G., Alagappan R., Frampton G.M., Xu P., Muffat J., et al. Derivation of pre-X inactivation human embryonic stem cells under physiological oxygen concentrations. Cell 2010, 141:872-883.
38. Enver T., Soneji S., Joshi C., Brown J., Iborra F., Orntoft T., Thykjaer T., Maltby E., Smith K., Abu Dawud R., et al. Cellular differentiation hierarchies in normal and culture-adapted human embryonic stem cells. Hum Mol Genet 2005, 14:3129-3140.
39. Wu H., Luo J., Yu H., Rattner A., Mo A., Wang Y., Smallwood P.M., Erlanger B., Wheelan S.J., Nathans J. Cellular resolution maps of X chromosome inactivation: implications for neural development, function, and disease. Neuron 2014, 81:103-119.